3-13321672-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_024923.4(NUP210):c.5079C>T(p.Ala1693=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000393 in 1,614,066 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00023 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00041 ( 5 hom. )
Consequence
NUP210
NM_024923.4 synonymous
NM_024923.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.28
Genes affected
NUP210 (HGNC:30052): (nucleoporin 210) The nuclear pore complex is a massive structure that extends across the nuclear envelope, forming a gateway that regulates the flow of macromolecules between the nucleus and the cytoplasm. Nucleoporins are the main components of the nuclear pore complex in eukaryotic cells. The protein encoded by this gene is a membrane-spanning glycoprotein that is a major component of the nuclear pore complex. Multiple pseudogenes related to this gene are located on chromosome 3. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 3-13321672-G-A is Benign according to our data. Variant chr3-13321672-G-A is described in ClinVar as [Benign]. Clinvar id is 758082.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NUP210 | NM_024923.4 | c.5079C>T | p.Ala1693= | synonymous_variant | 36/40 | ENST00000254508.7 | |
NUP210 | XM_047447795.1 | c.2463C>T | p.Ala821= | synonymous_variant | 18/22 | ||
NUP210 | XM_047447797.1 | c.2430C>T | p.Ala810= | synonymous_variant | 18/22 | ||
NUP210 | XM_047447796.1 | c.2394C>T | p.Ala798= | synonymous_variant | 18/22 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NUP210 | ENST00000254508.7 | c.5079C>T | p.Ala1693= | synonymous_variant | 36/40 | 2 | NM_024923.4 | P1 | |
NUP210 | ENST00000695491.1 | n.3081C>T | non_coding_transcript_exon_variant | 22/22 | |||||
NUP210 | ENST00000695490.1 | c.*507C>T | 3_prime_UTR_variant, NMD_transcript_variant | 18/22 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152068Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
34
AN:
152068
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000704 AC: 177AN: 251474Hom.: 1 AF XY: 0.000993 AC XY: 135AN XY: 135914
GnomAD3 exomes
AF:
AC:
177
AN:
251474
Hom.:
AF XY:
AC XY:
135
AN XY:
135914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000410 AC: 599AN: 1461880Hom.: 5 Cov.: 31 AF XY: 0.000567 AC XY: 412AN XY: 727240
GnomAD4 exome
AF:
AC:
599
AN:
1461880
Hom.:
Cov.:
31
AF XY:
AC XY:
412
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000230 AC: 35AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74424
GnomAD4 genome
AF:
AC:
35
AN:
152186
Hom.:
Cov.:
33
AF XY:
AC XY:
25
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 10, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at